Mitomycin C (C007B-232630)

DescriptionMitomycin C is a systemic chemotherapy compound and an antibiotic obtained fromStreptomyces caespitosus. It is the first bioreductive alkylating agent to be identified and is a derivative of 3-amino-5-hydroxybenzoic acid (AHBA), D-glucosamine, L-methionine and carbamoyl phosphate.Chemical structure: AziridineMitomycin C fromStreptomyces caespitosushas been used for the treatment of feeder layers such as, PMEF (primary mouse embryonic fibroblasts) and CD1 mouse embryonic fibroblasts (MEFs) for the culture of hESCs (human embryonic stem cells). It has also been used for the treatment of BLC (basal-like cancer) cell line.λmax；216, 359 nm. Specification: from Streptomyces caespitosus, 98% MDL Number: MFCD00078109 Molecular Formula: C15H18N4O5 Molecular Weight: 334.33 PubChem CID: 5746 Isomeric SMILES: CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N Beilstein Registry Number: 7231816 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/M476633-SCI_89194e73922ef62b9c9645a1842fbace.pdf

UPC:

51111733

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

Yes

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

M476633-25mg

CAS:

50-07-7

Health Hazards:

Toxic

Product Size:

25mg

Hazard Statement Codes:

H300

Precautionary Statement Codes:

P264:P301+P310